How is IQVIA (IQV) doing?
IQVIA is a company in the medical, diagnostics & research industry, based in Durham, NC, worth $42.8B. Here is how its shares and business compare with the rest of the market, and where it shows up on our dashboards.
Updated Oct 9, 2026
Middling
IQVIA shares are up 30% over the past year, 12 points ahead of the S&P 500. Its type is Faith Trade. Among large US stocks and funds it ranks in the 80th percentile on market beat, the 54th on staying power and the 48th on business growth. It appears on 2 of our dashboards.
Compare with CRL · MEDP · CERT · VEEV · TMO
Financials, earnings and news on Stox ›The past year
Price against the S&P 500, each set to $100 a year ago. Score is its weekly rank against the market. Select a tile for that score month by month.
What kind of stock is it?
Its type on Stox Atlas, from its four scores: beating or lagging the market, a steady or erratic rank, a growing or slowing business, and whether buyers or sellers lead.
Faith Trade
Beating the market steadily with buyers in control, though its business growth trails most. The price is ahead of the numbers.
Faith Trade since Sep; Speculative Pop before that.
Also Faith Trade (62 in all): CRL · RVTY · ACHC · MRK · PFE · MRNA
How is it doing against its group?
Its group is Health care, 86 large US stocks and funds whose prices tend to move together. Tools, biotech and large-cap pharma — defensive growth.
IQVIA is +30% over the past year, against +20% for the rest of the group and +16% for the S&P 500. It ranks 28th of 86 in Health care.
How much does it move?
Its typical daily move, against its own past year, the market and other large stocks. Swings describe risk, not direction.
About usual IQVIA typically moves 2.9% in a day, about usual for it, and it swings more than 60% of large US stocks.
IQV on our dashboards
Every question where IQVIA appears, in the order of the home page, with its reading and place in that table. Select a question to open it with IQV highlighted. Select a column to sort.
| Question | Reading | Place | Details |
|---|---|---|---|
| Is the market rewarding earnings beats? Earnings | –Beat | 16 of 60 | Surprise +4% · Move vs S&P +17.4% · Reported 2026-07-28 |
| Which companies grow earnings every year? Business quality | 97Long run | 17 of 60 | Years of growth 6 years · Growth, 5Y +41% a yr · Latest EPS 7.84 |
Go deeper on Stox
IQV’s full profile: financial statements, earnings and analysts’ estimates, valuation against its sector, recent news with a summary, and its scores in detail.
How to read this page
How it’s measured. Scores from Stox rank the stock against about 1,200 S&P 500, Nasdaq-100 and Russell 1000 stocks and popular funds, where 100 is best; market beat and staying power use prices, business growth uses revenue, margins and cash flow. Readings on other dashboards come from this site’s pages.
Sources. Daily prices and company financial statements from Financial Modeling Prep; scores and co-movement groups from Stox.
Scores are percentiles: 80 means the stock ranks above 80% of the others on that measure. They describe the recent past and are not advice or a forecast.
Its type follows Stox Atlas: each of the four scores is split at 50. “Steady” means its rank has held, high or low, so it says nothing on its own about direction.
Its group is the cluster of large US stocks whose prices have moved together over five years, with the market’s own moves taken out. The typical daily move is the average true range over 14 days, a measure of how far the price travels in a day including overnight gaps.
For financial statements, earnings and news, see IQV’s full profile on Stox.
This page is information, not investment advice. About our data and methods ›